 CAMBRIDGE, Mass., Jan. 12, 2023 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR, a clinical-stage cell and genome engineering company, today announced that it will participate virtually in B. Riley Securities 3rd Annual Oncology Conference. 